FDA Updates Staff Policy for Communicating New Drug Approvals

Drug Industry Daily
The FDA has added flow charts and removed references to the now-defunct CDER Fax-On Demand system in its updated policy on how the agency goes about posting approval letters for new NDAs, ANDAs, BLAs and supplements.

To View This Article:


Subscribe To Drug Industry Daily